Burcu Çakar

5PUBLICATIONS
71CO-AUTHORS
Optical technologyCancer therapy (excl. chemotherapy and radiation therapy)Clinical midwiferyPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG).

Sercan On, Selin Cebeci, Zeynep Hande Turna

|Apr 21, 2023
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.

Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan

|May 20, 2021
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.

Aykut Bahçeci, Semra Paydaş, Naziye Ak

|Jul 18, 2019
Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter Study.

Vahit Özmen, Burcu Çakar, Erhan Gökmen

|Oct 06, 2018
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome.

Burcu Çakar, Zeki Sürmeli, Pınar Gürsoy Öner

Pageof 1

Frequent Collaborators

2 joint publications

Sadettin Kılıçkap

2 joint publications

Erdem Çubukçu

1 joint publications

Zeki Sürmeli

1 joint publications

Pınar Gürsoy Öner